Cargando…
Apoptotic Death of Cancer Stem Cells for Cancer Therapy
Cancer stem cells (CSCs) play crucial roles in tumor progression, chemo- and radiotherapy resistance, and recurrence. Recent studies on CSCs have advanced understanding of molecular oncology and development of novel therapeutic strategies. This review article updates the hypothesis and paradigm of C...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057734/ https://www.ncbi.nlm.nih.gov/pubmed/24823879 http://dx.doi.org/10.3390/ijms15058335 |
_version_ | 1782321021098917888 |
---|---|
author | He, Ying-Chun Zhou, Fang-Liang Shen, Yi Liao, Duan-Fang Cao, Deliang |
author_facet | He, Ying-Chun Zhou, Fang-Liang Shen, Yi Liao, Duan-Fang Cao, Deliang |
author_sort | He, Ying-Chun |
collection | PubMed |
description | Cancer stem cells (CSCs) play crucial roles in tumor progression, chemo- and radiotherapy resistance, and recurrence. Recent studies on CSCs have advanced understanding of molecular oncology and development of novel therapeutic strategies. This review article updates the hypothesis and paradigm of CSCs with a focus on major signaling pathways and effectors that regulate CSC apoptosis. Selective CSC apoptotic inducers are introduced and their therapeutic potentials are discussed. These include synthetic and natural compounds, antibodies and recombinant proteins, and oligonucleotides. |
format | Online Article Text |
id | pubmed-4057734 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Molecular Diversity Preservation International (MDPI) |
record_format | MEDLINE/PubMed |
spelling | pubmed-40577342014-06-16 Apoptotic Death of Cancer Stem Cells for Cancer Therapy He, Ying-Chun Zhou, Fang-Liang Shen, Yi Liao, Duan-Fang Cao, Deliang Int J Mol Sci Review Cancer stem cells (CSCs) play crucial roles in tumor progression, chemo- and radiotherapy resistance, and recurrence. Recent studies on CSCs have advanced understanding of molecular oncology and development of novel therapeutic strategies. This review article updates the hypothesis and paradigm of CSCs with a focus on major signaling pathways and effectors that regulate CSC apoptosis. Selective CSC apoptotic inducers are introduced and their therapeutic potentials are discussed. These include synthetic and natural compounds, antibodies and recombinant proteins, and oligonucleotides. Molecular Diversity Preservation International (MDPI) 2014-05-12 /pmc/articles/PMC4057734/ /pubmed/24823879 http://dx.doi.org/10.3390/ijms15058335 Text en © 2014 by the authors; licensee MDPI, Basel, Switzerland http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Review He, Ying-Chun Zhou, Fang-Liang Shen, Yi Liao, Duan-Fang Cao, Deliang Apoptotic Death of Cancer Stem Cells for Cancer Therapy |
title | Apoptotic Death of Cancer Stem Cells for Cancer Therapy |
title_full | Apoptotic Death of Cancer Stem Cells for Cancer Therapy |
title_fullStr | Apoptotic Death of Cancer Stem Cells for Cancer Therapy |
title_full_unstemmed | Apoptotic Death of Cancer Stem Cells for Cancer Therapy |
title_short | Apoptotic Death of Cancer Stem Cells for Cancer Therapy |
title_sort | apoptotic death of cancer stem cells for cancer therapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057734/ https://www.ncbi.nlm.nih.gov/pubmed/24823879 http://dx.doi.org/10.3390/ijms15058335 |
work_keys_str_mv | AT heyingchun apoptoticdeathofcancerstemcellsforcancertherapy AT zhoufangliang apoptoticdeathofcancerstemcellsforcancertherapy AT shenyi apoptoticdeathofcancerstemcellsforcancertherapy AT liaoduanfang apoptoticdeathofcancerstemcellsforcancertherapy AT caodeliang apoptoticdeathofcancerstemcellsforcancertherapy |